MediaTek (OTC:MDTTF) Stock, Quote.Headers.trade-ideas

Founded in 1997, MediaTek is a fabless semiconductor designer focusing on solutions for smartphones, digital televisions, and connectivity products. The business is divided into three segments. The first is "mobile," which accounts for around half of sales, where MediaTek is the second-largest third-party supplier of smartphone SoCs to the likes of Xiaomi and Vivo. The second is "smart edge," which accounts for just over 40% of sales, that covers most devices other than smartphones. The third is "power IC" that includes power management products for mobile devices, data centers, connectivity devices and more. Mediatek is headquartered in Hsinchu, Taiwan and employs almost 22,000 people.

Semiconductor.Shutterstock

Asia

Earnings

Equities

News

Markets

Tech

ASML

MDTTF

NVDA

TSMC, the world&#39;s leading producer of advanced processors, saw its shares fall by over 1% on Wednesday morning. TSMC is responsible for manufacturing chips for companies like Nvidia and Apple. ASML, a Dutch semiconductor equipment manufacturer, experienced a 2.09% drop in its Nasdaq-listed shares on Tuesday

TSMC, ASML And Other Chip Stocks Slide As Market Anticipates Nvidia&#39;s Earnings Report Impact

MediaTek Inc

Trading Ideas

ZSPC

zSpace Shares Halted On Circuit Breaker To The Downside

IPOs

zSpace Shares Open For Trade At $5.80/Share; IPO Priced At $5/Share

Aegis Capital analyst David Bouchey reiterates Sunshine Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) with a Buy and maintains $15 price target.

Price Target

Reiteration

Analyst Ratings

SBFM

Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $15 Price Target

On Thursday, CG Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) revealed topline data from the Phase 3 BOND-003 trial in patients with high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) unresponsive to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42335403/groundbreaking-cretostimogene-grenadenorepvec-monotherapy-data-demonstrates-sustained-durable-comp" rel="noreferrer noopener">Bacillus Calmette Guerin (BCG)</a>.
The trial demonstrated that 74.5% of patients (82 out of 110) achieved a complete response (CR) at any time after receiving treatment with cretostimogene as a single agent.
The median duration of response (DOR) has not been reached but exceeds 27 months as of the data cutoff of September 30.
The data will be presented at the Society of Urologic Oncology Annual Meeting.
Gary Steinberg, Professor, Department of Urology at Rush University Medical Center, said, &#8220;I am very encouraged by the latest data from the BOND-003 study, which demonstrates cretostimogene&#8217;s compelling efficacy as well as its potential to induce a best-in-class durable response in NMIBC patients, with 63.5% of patients remaining in response at 12 months or greater and 56.6% of patients remaining in response at 24 months or greater, by K-M estimate. Additionally, 97.3% of patients were free from progression to Muscle Invasive Bladder Cancer (MIBC) at 12 months.&#8221;
No Grade 3 or greater treatment-related adverse events (TRAEs) or deaths were reported. No treatment-related discontinuation of cretostimogene was observed.
97.3% of patients completed all expected treatments.
As of September 30, 2024, cash and cash equivalents and marketable securities were $540.7 million, which is expected to be sufficient to fund <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41898434/cg-oncology-reports-third-quarter-2024-financial-results-and-provides-business-updates" rel="noreferrer noopener">operations through 2027</a>.
Price Action: CGON stock is down 5.67% at $33.88 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/mid-cap/24/12/42325352/why-is-zeta-global-stock-soaring-on-wednesday" target="_blank" rel="noreferrer noopener">Why Is Zeta Global Stock Soaring On Wednesday?</a></li>
</ul>

Biotech

Health Care

Movers

General

CGON

CG Oncology Touts Encouraging Data From Late-Stage Study Of Bladder Cancer Candidate

WIIM

LYFT

UBER

Shares of ride-sharing companies are trading lower following a report that Waymo will launch in Miami in 2026.

Truist Securities analyst Ki Bin Kim maintains Americold Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COLD#NYSE">COLD</a>) with a Buy and lowers the price target from $33 to $30.

COLD

Truist Securities Maintains Buy on Americold Realty Trust, Lowers Price Target to $30

PPBT

Purple Biotech Shares Resume Trade

Truist Securities analyst Ki Bin Kim maintains Acadia Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKR#NYSE">AKR</a>) with a Hold and raises the price target from $23 to $27.

Truist Securities Maintains Hold on Acadia Realty Trust, Raises Price Target to $27

Redfin's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NYSE">RDFN</a>) short percent of float has fallen 14.94% since its last report. The company recently reported that it has 18.43 million shares sold short, which is 17.82% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.63 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Redfin Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733416222_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Redfin has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Redfin's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Redfin's peer group average for short interest as a percentage of float is 5.34%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

RDFN

Looking Into Redfin's Recent Short Interest

Affirm Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NYSE">AFRM</a>) short percent of float has risen 9.24% since its last report. The company recently reported that it has 20.03 million shares sold short, which is 7.45% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.32 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Affirm Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733416216_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Affirm Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Affirm Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Affirm Holdings's peer group average for short interest as a percentage of float is 4.68%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

AFRM

Peering Into Affirm Holdings's Recent Short Interest

Bank of America significantly raised Tesla Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) 12-month price target from $350 to $400, maintaining a Buy rating as the investment bank bets on the company&#8217;s ability to balance strong near-term growth in electric vehicles with bold long-term plays in <a href="https://www.benzinga.com/electric-vehicles">autonomous driving and robotics.</a>
In a note to clients Thursday, analyst John Murphy highlighted his optimism following a recent visit to Tesla's Gigafactory in Austin, Texas.
"The trip gave us increased confidence that Tesla is well-positioned to grow in 2025+," Murphy said, citing discussions with investor relations, a factory tour, and test drives that showcased Tesla's technological advancements.
<h3 class="wp-block-heading">FSD Advances Bolster Robotaxi Prospects</h3>
Tesla's Full Self-Driving (FSD) technology stood out during the test drive at Gigafactory Austin, with vehicles demonstrating significant improvements. 
Murphy highlighted how Tesla's Cybertruck and Model Y seamlessly navigated construction zones and managed a challenging left turn against traffic.
"Tesla noted that soon its FSD will require an intervention only once every 10,000 miles," Murphy said, emphasizing that the company's autonomous technology is nearing the safety level required to launch a monitored robotaxi service. 
For comparison, Alphabet Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Waymo initiated its robotaxi operations after achieving one intervention every 17,000 miles, &#8220;a milestone TSLA believes it could achieve shortly with its growing AI compute.&#8221; 
Murphy highlighted Tesla's growing AI infrastructure, which includes 50,000 active Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) H100 chips as of October. This positions the company to potentially launch its robotaxi service by 2025.
<h3 class="wp-block-heading">Optimus: Tesla's Robot Revolution</h3>
Tesla's humanoid robot, Optimus, is already making strides in automation.
Though Optimus currently accounts for just a single-digit percentage of Tesla's AI compute power, Murphy expects this to increase as the robotaxi program stabilizes, accelerating Optimus&#8217; development.
"With more robots in use, training will accelerate," he said, adding that mass production in 2026 and beyond could drive down costs and open new growth avenues for Tesla.
Murphy also indicated Tesla may consider raising capital to support its investments in Optimus, robotaxis, and artificial intelligence. 
"At its current valuation, Tesla could raise $50 billion+ through an equity raise at a relatively modest 4-5% dilution to shareholders," Murphy stated. 
&#8220;TSLA has historically been able to raise capital at an extremely low cost compared to its peers,&#8221; he added.
<h3 class="wp-block-heading">Lower-Cost EV And Expanding TAM</h3>
Tesla plans to launch a lower-cost EV in the first half of 2025, targeting a price point below $30,000, which includes the $7,500 federal EV tax credit. 
Murphy said this vehicle could expand Tesla's total addressable market (TAM), with cost savings achieved through &#8220;a number of areas such as de-contenting, making the motor more efficient and thereby enabling a smaller battery, and changing the interior.&#8221;
<h3 class="wp-block-heading">Market Reactions</h3>
Shares of Tesla rose by 3.8% to $371.52 on Thursday, reaching levels last seen in early April 2022, pushing year-to-date gains to 50%.
The all-time highs of $414 reached in November 2021 are now approximately 10% above current prices.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42321567/amazon-hits-all-time-highs-eyes-best-2-year-rally-since-2010-cyber-season-marks-record-sales-aws-shines-with-ai-innovations">Amazon Hits All-Time Highs, Eyes Best 2-Year Rally Since 2010: Cyber Season Marks Record Sales, AWS Shines With AI Innovations</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Analyst Color

Large Cap

GOOG

GOOGL

TSLA

Tesla's Path To $400: Bank Of America Highlights EV, AI Growth

AGNC Investment's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NYSE">AGNC</a>) short percent of float has fallen 16.26% since its last report. The company recently reported that it has 42.25 million shares sold short, which is 4.79% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.07 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AGNC Investment Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733416211_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AGNC Investment has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AGNC Investment's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AGNC Investment's peer group average for short interest as a percentage of float is 7.13%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

AGNC

Looking Into AGNC Investment's Recent Short Interest

Truist Securities analyst Joseph Civello initiates coverage on VF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) with a Hold rating and announces Price Target of $20.

Initiation

Truist Securities Initiates Coverage On VF with Hold Rating, Announces Price Target of $20

Citigroup analyst Jason Gursky maintains TransDigm Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>) with a Buy and raises the price target from $1563 to $1600.

Citigroup Maintains Buy on TransDigm Gr, Raises Price Target to $1600

Purple Biotech Shares Halted On Circuit Breaker To The Downside, Stock Now Down -29.2%

Seaport Global analyst Daniel Mckenzie upgrades American Airlines Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) from Neutral to Buy and maintains the price target from $20 to $20.

Upgrades

Seaport Global Upgrades American Airlines Gr to Buy, Maintains Price Target to $20

Citigroup analyst Paul Lejuez maintains Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) with a Neutral and raises the price target from $64 to $76.

DLTR

Citigroup Maintains Neutral on Dollar Tree, Raises Price Target to $76

Citigroup analyst Jason Bazinet maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Neutral and raises the price target from $725 to $920.

NFLX

Citigroup Maintains Neutral on Netflix, Raises Price Target to $920

Trading Halt: Halt status updated at 11:25:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

MicroStrategy Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) leveraged ETFs have <a href="https://www.benzinga.com/crypto">amplified the company&#8217;s role</a> as a de facto Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) proxy.
According to JPMorgan analyst Nikolaos Panigirtzoglou, these ETFs — Defiance Daily Target 2x Long MSTR ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTX#NASDAQ">MSTX</a>) and the T-Rex 2X Long MSTR Daily Target ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/MSTU#BATS">MSTU</a>) — have fueled record inflows and significantly impacted MicroStrategy's stock volatility and valuation.
Leveraged ETFs tied to MicroStrategy stock accounted for $3.4 billion of November's $11 billion inflows into crypto markets, Panigirtzoglou notes. 
These ETFs, designed to offer amplified exposure to Bitcoin through MicroStrategy's stock, are increasingly popular among retail investors who lack access to direct Bitcoin ETFs. This surge underscores their growing importance in facilitating Bitcoin exposure via equity markets.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42275232/leveraged-microstrategy-etfs-are-playing-with-fire-experts-warn">Leveraged MicroStrategy ETFs Are Playing With Fire, Experts Warn</a>
<h2 class="wp-block-heading">Rebalancing Flows Amplify Stock Volatility</h2>
Daily rebalancing of these ETFs magnifies volatility in MicroStrategy's stock. The &#8220;price-insensitive&#8221; nature of these flows, as described by Panigirtzoglou, exacerbates market moves, particularly during end-of-day trading. 
In November, there were five instances where rebalancing flows exceeded $2 billion in a single day. This contributed to the stock's near 60% surge during the month.
<h2 class="wp-block-heading">A Premium On Bitcoin Exposure</h2>
MicroStrategy's stock trades at a premium, reflecting factors like its <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/39045022/microstrategys-big-move-from-bitcoin-bet-to-russell-1000-inclusion">inclusion in indices</a> like MSCI World, enabling passive inflows, and its leveraged Bitcoin acquisition strategy. 
MicroStrategy &#8220;offers a way for those investors restricted from investing in spot bitcoin ETFs to gain bitcoin exposure,&#8221; Panigirtzoglou said.
The company also serves as an &#8220;equivalent to a leveraged bitcoin fund (given its issuance of both equity and debt to acquire bitcoins),&#8221; he added.
With $17 billion spent on Bitcoin in 2024, including $13 billion this quarter alone, MicroStrategy's leveraged ETFs have become a linchpin in its Bitcoin acquisition strategy, reshaping its market presence and redefining how retail investors access crypto.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/42208970/microstrategy-linked-etfs-skyrocket-400-this-year-is-this-the-michael-saylor-effect">MicroStrategy-Linked ETFs Skyrocket 400% This Year: Is This &#8216;The Michael Saylor Effect&#8217;?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Fintech news covering the emerging Financial Technology services sector

Fintech

Long Ideas

Specialty ETFs

ETFs

$BTC

MSTR

ETF Opportunities Trust T-Rex 2X Long MSTR Daily Target ETF

MSTU

MSTX

How Leveraged MicroStrategy ETFs Are Powering The Bitcoin Surge

Meta's Llama 3.2 lightweight language models fit on device

MediaTek: All About AI

FLTW: Long-Term Growth Prospect Intact, But Quite Expensive Now

BlackRock Advantage Emerging Markets Fund Q3 2024 Commentary

Invesco EQV Emerging Markets All Cap Fund Q3 2024 Commentary

Invesco EQV Asia Pacific Equity Fund Q3 2024 Commentary

Qualcomm: Take Time To Savor Its AI Gains

Janus Henderson Global Equity Income Fund Q3 2024 Commentary

Janus Henderson Responsible International Dividend Fund Q3 2024 Commentary

Columbia Emerging Markets Fund Q3 2024 Commentary

AAGIY

AAIGF

AAPL

ARLUF

AVGO

AXAHF

AXAHY

BABA

BDMSF

BDOUF

BDOUY

BDULF

BDUUF

BDUUY

BKLN

BKRKF

BKRKY

BMYMP

BOIVF

BPAQF

BTAFF

CPNNF

CQQQ

DTEGF

DTEGY

FLTW

GEDSF

HBCYF

HEINY

HINKF

HKXCF

HKXCY

HSBC

HXSCF

IFNNF

IFNNY

INFY

KBWB

KBWD

KBWY

KCDMF

KCDMY

LTOUF

MELI

MMYT

MPNGF

MPNGY

MSFT

NGGTF

NONOF

PBCRF

PBCRY

PCCYF

PCEF

PDBC

PDRDF

PIAIF

PNGAY

PNQI

PRFZ

PRNDY

PTPKF

PTRRY

QCOM

QQQJ

QQQM

RBSPF

RELX

RGEDF

RLXXF

RSPT

RTNTF

RTPPF

SNEJF

SONY

SOXQ

SOXX

SPGP

SPHB

SPHD

SPHQ

SPLV

SPMO

SSNLF

TCEHY

TCOM

TCTZF

TNGCF

TOELF

TOELY

TRPCF

TSCDF

TSCDY

TSMWF

TTNDF

UNLYF

VALE

WMMVF

Comments

MediaTek

MediaTek (MDTTF) Forecast

MediaTek (OTC:MDTTF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga